Drug Type Small molecule drug |
Synonyms Pivaloyloxymethylbutyrate, Pivanex, AN 9 + [1] |
Target |
Action inhibitors |
Mechanism HDAC inhibitors(Histone deacetylase inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H18O4 |
InChIKeyGYKLFBYWXZYSOW-UHFFFAOYSA-N |
CAS Registry122110-53-6 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Recurrent Chronic Lymphoid Leukemia | Phase 2 | United States | 01 May 2004 | |
| Small Lymphocytic Lymphoma | Phase 2 | United States | 01 May 2004 | |
| Melanoma | Phase 2 | United States | 01 Jan 2004 | |
| Advanced Lung Non-Small Cell Carcinoma | Phase 2 | United States | 01 Sep 2003 | |
| Advanced Lung Non-Small Cell Carcinoma | Phase 2 | India | 01 Sep 2003 | |
| Advanced Lung Non-Small Cell Carcinoma | Phase 2 | United Kingdom | 01 Sep 2003 | |
| Liver Cancer | Phase 2 | United States | - | - |
| Liver Cancer | Phase 2 | - | - | |
| Liver Cancer | Phase 2 | - | - | |
| Non-Small Cell Lung Cancer | Phase 2 | - | - |





